Citation Impact
Citing Papers
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Feedback activation of factor XI by thrombin does not occur in plasma
2007
Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations
1997
Mechanisms of Thrombus Formation
2008 Standout
Sox9 Modulates Proliferation and Expression of Osteogenic Markers of Adipose-Derived Stem Cells (ASC)
2013 Standout
NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata
1994 StandoutNobel
Pathways for bradykinin formation and inflammatory disease
2002
Juvenile idiopathic arthritis
2007 Standout
The Serine Protease Plasmin Triggers Expression of MCP-1 and CD40 in Human Primary Monocytes via Activation of p38 MAPK and Janus Kinase (JAK)/STAT Signaling Pathways
2002
The molecular basis of blood coagulation
1988 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.
1998
Kinin Formation: Mechanisms and Role in Inflammatory Disorders
1988
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
1997 StandoutNature
Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces
2004 StandoutNobel
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Effects of the Bradykinin Antagonist Bradycor™ (Deltibant, CP-1027) in Severe Traumatic Brain Injury: Results of a Multi-Center, Randomized, Placebo-Controlled Trial
1999
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Kinin‐generating Cascade in Advanced Cancer Patients and in vitro Study
1991
Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents
1992 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Endocrine Regulation of Energy Metabolism by the Skeleton
2007 Standout
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
2008
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases
1998
Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy
2002
Moderate and severe traumatic brain injury in adults
2008 Standout
Platelets, Complement, and Contact Activation: Partners in Inflammation and Thrombosis
2011
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
Points of control in inflammation
2002 StandoutNature
Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor
1992 Standout
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
2000 Standout
Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti‐rheumatic therapy
2007
Evidence for Cytokine Mediation of Disease Expression in Adults Experimentally Infected with Influenza A Virus
1999
Thrombosis as an intravascular effector of innate immunity
2012 Standout
The plasminogen activation system in inflammation
2008
The immunopathogenesis of sepsis
2002 StandoutNature
IgE, mast cells, basophils, and eosinophils
2010 Standout
Contact activation of blood coagulation is inhibited by plasma factor XIII b-chain
1988
Molecular cloning and expression of human hepatocyte growth factor
1989 StandoutNature
Prorenin and Other Large Molecular Weight Forms of Renin*
1980
Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation
1991
Development of the human coagulation system in the full-term infant
1987 Standout
Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.
1995
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
Efficacy and safety of aprotinin in aortocoronary bypass and valve replacement operations: a placebo-controlled randomized double-blind study
1996
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
1993 StandoutNobel
Urticaria and Angioedema
1979
Etiology and Pathogenesis of Rheumatoid Arthritis
1971
Pro-Carboxypeptidase R is an Acute Phase Protein in the Mouse, Whereas Carboxypeptidase N Is Not
2000 StandoutNobel
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
2009 Standout
Cell mediated immunity and the inflammatory system
1976 StandoutNobel
Subpopulations of human peripheral T gamma delta lymphocytes
1989
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Physiologic manifestations of human anaphylaxis.
1980
Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats
1993
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Physiologic and pathologic manifestations of lymphokine action
1986 StandoutNobel
Chemotaxis of human basophil leucocytes.
1972
A simple screening test for evaluating prolonged partial thromboplastin times in newborn infants
1982
Activation of the classical pathway of complement by Hageman factor fragment.
1981
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin.
1986
Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis
2009
The Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation
1984
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
1988 Standout
Transglutaminases: multifunctional cross‐linking enzymes that stabilize tissues
1991 Standout
Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes
1997
Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.
1983
Intrinsic Pathway of Coagulation and Arterial Thrombosis
2007
Matrix Metalloproteinases: A Review
1993 Standout
Tumors: Wounds That Do Not Heal
1986 Standout
cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family.
1989 StandoutNobel
Interaction of human plasma kallikrein and its light chain with C.hivin.1 inhibitor
1983
Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials
1994
Airborne transmission of respiratory viruses
2021 StandoutScience
Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma
1982
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Works of Kaplan Ap being referenced
Intrinsic coagulation, thrombosis, and bleeding [letter]
1996
The effect of C1 inhibitor upon Hageman factor autoactivation
1986
The coagulation-kinin pathway of human plasma
1987
Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein
1992
Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.
1978
Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen
1979
Activation of factor XI in plasma is dependent on factor XII [see comments]
1993
Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma
1988
Intrinsic coagulation, thrombosis, and bleeding [letter]
1996
Initiation of contact activation of human plasma.
1983
Activation of Hageman factor by proteases released during antigen challenge of human lung.
1981
Pattern of nasal secretions during experimental influenza virus infection.
1996
A pre-albumin activator of prekallikrein.
1970
Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
1983
Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains
1993
Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity
1989
The coagulation-kinin pathway of human plasma
1987
Prevalence of IgE rheumatoid factor (IgE RF) in mixed cryoglobulinemia and rheumatoid arthritis.
1987
The effect of C1 inhibitor upon Hageman factor autoactivation
1986
Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen
1979